CD22 and acute promyelocytic leukemia: Basophilic differentiation, manifested by the expression of CD203c and/or CD22, has been reported in up to one-third of APL cases at presentation [59,63,64] and is also observed in patients after all-trans retinoic acid (ATRA) and/or arsenic trioxide therapy [65,66] (Figure 3).